Amoxicillin orally disintegrating tablet and preparation method thereof

A technology of orally disintegrating tablets and amoxicillin, which is applied in the field of amoxicillin orally disintegrating tablets and its preparation, can solve problems such as unsatisfactory effects and ineffective treatment effects, and achieve stable properties, rapid results, and convenient oral administration Effect

Inactive Publication Date: 2017-09-01
NINGBO SHUANGWEI PHARMA
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented innovative medicine called Disintegratablets contains certain ingredients like Amoxylling Bone Acquisition (Amoxil) which helps break down hardened teeth quickly without damaging them too much. These products are easy to administer with good taste and quicker onset compared to other methods such as mouthwashes containing antibiotics. They can be used effectively against various diseases associated with these conditions including pneumonia due to Gram negative microorganisms from cystic fibrosis patients who have been treated with Antimicrobial Agents.

Problems solved by technology

The technical problem addressed by this patented method for treating dentitis caused by certain types of gram negative microorganisms involves finding an alternative way to effectively administer these drugs without causing side effects such as stomach fluke symptoms (gastroenteropathy).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amoxicillin orally disintegrating tablet and preparation method thereof
  • Amoxicillin orally disintegrating tablet and preparation method thereof
  • Amoxicillin orally disintegrating tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Concrete each component consumption ratio is as shown in table 1 below:

[0026] Table 1

[0027]

[0028] Concrete preparation steps:

[0029] 1. Main drug granules: Amoxicillin (light powder) and silicon dioxide are placed in a wet granulator and mixed evenly, then an appropriate amount of 95% ethanol (volume percentage) of 5% K30 is added, the soft material is passed through 18 mesh, and dried at 40°C After 3-4 hours, granulate with 18 mesh sieve.

[0030] 2. Auxiliary material granules: except those added, use 5% K30 (75% ethanol) solution in an appropriate amount for the remaining adjuvant (croscarmellose sodium 1 / 2). Pass the soft material through 18-mesh sieve, dry at 60°C for 3-4 hours, and granulate with 18-mesh sieve.

[0031] 3. Total blending: main drug granules, excipient granules and external excipients.

[0032] 4. Tablet compression: Tablet compression is performed according to the particle content, and the pressure is controlled at about 1.5-3KG t

Embodiment 2

[0051] Table 7 Small scale scale-up of 100,000 prescriptions

[0052]

[0053] Concrete preparation steps are:

[0054] 1. Glycine and anhydrous citric acid were crushed to 80 meshes respectively. The croscarmellose sodium, microcrystalline cellulose and aspartame were respectively passed through an 80-mesh sieve. The crushed and sieved raw and auxiliary materials are stored in a transfer barrel with a clean plastic bag and covered. Attach the material label and transport it to the weighing and batching room. The crushed and sieved raw materials should be used within 10 days.

[0055] 2. Granulation and mixing

[0056] a. Preparation of adhesive

[0057] Adhesive I: 0.4kg of povidone K30 was placed in a stainless steel barrel, and 8L of 95% ethanol was added, and stirred slowly until it was completely dissolved, to prepare a 5% povidone K30 ethanol solution as the adhesive I.

[0058] Adhesive II: 0.35kg of povidone K30 was placed in a stainless steel barrel, and 7L of 7

Embodiment 3

[0103] Table 15 Screening prescriptions (designed according to each prescription)

[0104]

[0105] The preparation process is the same as in Example 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an amoxicillin orally disintegrating tablet and a preparation method thereof. The orally disintegrating tablet comprises the following raw materials in parts by weight: granulation raw materials: 10 to 15 parts of amoxicillin, 1 to 3 parts of colloidal silicon dioxide, and 0.5 to 1 part of povidone K30; granulation auxiliary materials: 4 to 8 parts of microcrystalline cellulose, 0.2 to 0.6 part of aspartame, and 0.4 to 0.8 part of croscarmellose sodium; external auxiliary materials: 0.4 to 0.8 part of croscarmellose sodium, 0.1 to 0.2 part of magnesium stearate, and 0.4 to 0.8 part of orange flavor. The disintegrating tablet has the effects that an object product has stable characters through a reasonable formula, and specific dosage ratio and constituents among all the components, the disintegration time meets expectation, and contents of relevant matter and amoxicillin meet the requirements of standards.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner NINGBO SHUANGWEI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products